All BCCM News

January 13, 2017
Issues Brought Up During BC-CM Producers Group Meeting Featured By Inside EPA Article

On January 13, 2017, slides from the B&C® Consortia Management’s (BC-CM) NMP Producers Group Meeting with the Office of Management and Budget were discussed in the Inside EPA article “Chemical Makers Cite TSCA Listing In Call For EPA To Drop NMP Proposal.”

[…] But representatives from Bergeson & Campbell on behalf of NMP producers in a Dec. 5 meeting with EPA and OMB officials ahead of the proposal's release argued that the rulemaking does not appear to be consistent with the completed risk assessment and therefore may violate section 26 under the updated law.
NMP is used as an intermediate or a solvent in electronics, agricultural chemical, pharmaceutical, coating, petrochemical processing, and industrial and consumer cleaner sectors. The agency later last June indicated to industry that a supplemental risk assessment for NMP showed potential risk to consumers, according to industry slides presented by Bergeson & Campbell at the Dec. 5 meeting.

https://insideepa.com/daily-news/chemical-makers-cite-tsca-listing-call-epa-drop-nmp-proposal [subscription required]

November 7, 2016
Lauren M. Graham, Ph.D., Joins B&C Consortia Management

 

Bergeson & Campbell, P.C. (B&C®), The Acta Group (Acta®), and B&C® Consortia Management (BCCM) are pleased to announce that Lauren M. Graham, Ph.D., has joined our firms as Manager, BCCM.  In this role, Dr. Graham will guide and facilitate effective consortia performance in advocacy programs, public outreach, product stewardship, and testing and compliance.  She offers BCCM consortia clients scientific acumen gained in academia and industry, and organizational, editorial, and promotional skills honed while with the Royal Society of Chemistry (RSC), assisting consortia to reach and exceed their institutional goals. Lauren’s scientific background will also be put to good use for B&C and Acta clients.
 
Kathleen M. Roberts, Vice-President of BCCM commented regarding the appointment “I am delighted that Dr. Graham has joined the BCCM team.  Her project management talents, analytical capabilities, and communication skills make Lauren an invaluable asset to the BCCM consortia community.  In addition, Lauren’s extensive knowledge of chemistry and network of scientific contacts will benefit B&C and Acta clients looking for support and assistance with regulatory matters.”
 
Prior to joining BCCM, Dr. Graham was Assistant Editorial Development Manager at RSC. While there, she successfully managed hundreds of meetings with leading scientific researchers at universities and private industry.  She organized publishing workshops and analyzed publishing data trends, developing regional strategies to increase readership and the industry profile of journals under her supervision.  Dr. Graham also served as a graduate research assistant at the University of Maryland, College Park, Maryland, with a focus on nanotechnology and materials science.  She began her scientific career in the laboratory at DSM Nutritional Products, evaluating chemical and physical properties of raw materials. Her responsibilities included implementing Good Laboratory Practices (GLP) in the labs.
 
B&C® Consortia Management, L.L.C. (BCCM) provides core support services for industrial, agricultural, and biocide chemical advocacy, testing, and research consortia.  BCCM provides a full complement of consortia management services, including consortia formation, full financial services managed by a CPA, organizational support, administration services, and infrastructure/communication platforms.  BCCM also provides effective and efficient laboratory communication and management services for consortia that expend significant resources on study data production.  

BCCM is affiliated with Bergeson & Campbell, P.C. (B&C®), a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues; and with The Acta Group (Acta®), a scientific and regulatory consulting firm with offices in Washington D.C., Manchester England, and Beijing China, providing strategic, comprehensive support for global chemical registration, regulation, and sustained compliance.

March 8, 2016
B&C Consortia Management Spring 2016 Regulatory, Testing,  and Policy Outlook for Chemical Consortia

Click here for a PDF version of the memorandum.

The Business Wisdom of Consortia Advocacy

Engaging in advocacy opportunities with your company's competitor may seem counterintuitive in ultra-competitive times, but doing so as part of a consortium, in which your company benefits as well, makes sense. Working within a group to attain a shared goal offers benefits beyond cost savings. For example, the federal and international agencies prefer to work with coalitions to save time and leverage their resources; there is truth to the old adage, "There is strength in numbers." The beneficial outcome of competitors working together to elevate standards and business practices for the good of the whole is undeniable. Consolidating experience, knowledge, and finances allows consortium members to achieve far more and faster than they would individually.

The reasons for forming and maintaining a coalition are varied. There is great truth to the proverb, "Many hands make light work." As companies and related stakeholders consider the regulatory, policy, and stewardship challenges facing them today, they would be well-served to consider if it makes sense to tackle those challenges under a consortium umbrella. The likelihood is that an individual entity is not always well-suited to complete a costly testing program, influence policy change, or raise industry standards, but entities working together with a unified voice are.

In 2016, B&C® Consortia Management, L.L.C. (BCCM) will be leveraging its considerable resources on a wide range of advocacy, regulatory, science policy, testing, and communication activities for BCCM consortia members. BCCM is authorized to operate in the U.S. and Europe. We identify below specific initiatives, including group formation invited by regulatory actions, focused on needed policy changes or desires to improve worker safety. We invite stakeholders to consider whether they too should engage in any existing BCCM consortia, or to identify other testing or advocacy areas where consortia work makes sense.

Regulatory Triggers: Organize Now -- Before Final Action Is Taken

EPA Endocrine Disruptor Screening Program

Producers and importers of chemicals included in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program (EDSP) will be required to respond to test orders for their subject chemical(s). Given the high price tag of the EDSP test program, companies that continue to manufacture the listed chemicals will likely address the EDSP regulatory components within a consortium to share costs.

BCCM currently manages two groups focused on the EPA EDSP -- the N-Methylpyrrolidone Producers Group, Inc. (NMP Producers Group) and the MTBE Consortium -- and anticipates several more groups to organize in 2016. These groups appreciate that organizing efforts now -- before EPA formally issues EDSP test orders for their chemicals of interest -- is a smart strategic move. They have already begun the hard work of developing effective advocacy positions regarding testing needs and will be ready to engage immediately when EPA issues test orders.

Some companies may be concerned that forming or joining an EDSP consortium prior to the test order could result in an inequitable cost allocation. They fear that companies that choose not to join early will gain an advantage. This is incorrect. Under the EDSP, all companies that produce or import the subject chemical when the test order is issued must conduct the testing themselves, form or join a consortium that will conduct the testing, agree to provide fair and equitable reimbursement for testing conducted by others, or exit the market. Thus, there is no benefit to companies that choose not to proceed with a consortium. On the other hand, companies that opt to create or join an existing consortium will have the advantage of leading critical decisions on cost sharing, membership fees, and reimbursement provisions for late comers.

Through BCCM's affiliation with Bergeson & Campbell, P.C. (B&C®), its EDSP-focused groups have access to highly-experienced, sophisticated attorneys, scientists, and other non-legal professionals with significant expertise in regulatory law, science, data compensation, and EPA policy guidance. Test programs such as EDSP often present substantial risk information reporting questions, the answers to which experienced legal counsel may be needed. B&C is one of the few law firms in the country with a comprehensive domestic and international pesticide and industrial chemicals practice group.

BCCM is also an associate member of the Endocrine Policy Forum (EPF), a cooperative effort among EDSP stakeholders designed to facilitate communication, networking, and scientific dialogue on the testing program, interpretation of results, and guideline development.

While the EDSP test program does not mandate coordination prior to the issuance of test orders, sophisticated entities recognize that being a consortium member now allows adequate time comprehensively and thoughtfully to address administrative issues, agree upon cost sharing mechanisms, identify potential testing laboratories, retain experienced scientific consultants, and begin the important process of reviewing available data to support test waivers. These steps take time to do correctly, and waiting to form a consortium until EPA formally issues the test orders is unwise and disallows time to complete these tasks efficiently and effectively. Stakeholders need to be ready to engage in testing immediately, and will lack the necessary time to organize a group and secure limited testing capacity to fulfill the test orders.

TSCA Work Plan Chemicals

Updated in 2014, EPA maintains a list of 90 chemicals for assessment under the Toxic Substances Control Act (TSCA). Chemicals on this list will be subject to the TSCA Work Plan Chemical Assessment process that includes problem formulation, initial assessment, data needs assessment, final assessment, and potential risk management measures.

Of the currently completed assessments, BCCM groups engaged in two -- antimony trioxide (ATO) under the North American Metals Council (NAMC) and NMP under the NMP Producers Group. The ATO assessment concluded that no further work was necessary regarding the uses considered under the program. The NMP assessment concluded potential occupational risk for certain uses; the NMP Producers Group is actively engaged now with EPA on next steps. Several other BCCM groups have chemicals on the TSCA Work Plan list and will be well-positioned to engage when their chemical assessments are initiated.

Given concerns with the commercial impacts of an EPA assessment and possible use or application restrictions, companies with chemicals listed as TSCA Work Plan chemicals should be coordinating with other producers or importers now to be well-positioned to engage meaningfully in EPA's chemical assessment process. Similar to the EDSP work, entities should work together under the protection of a consortium structure before EPA initiates its Work Plan assessment. Preparatory actions by an organized group would include early advocacy with EPA regarding available hazard and exposure information, providing updates to EPA on any ongoing reviews or testing, and carefully reviewing existing data to identify potential gaps, particularly on use and exposure information.

Companies with commercial interests in Work Plan chemicals that delay action, based on the hope the program will go away, will be disappointed. It is well-recognized that the TSCA Work Plan Chemical Program is expected to be incorporated under TSCA reform legislation as the template for chemical prioritization for existing chemicals under a new TSCA framework.

FIFRA Activities

As part of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), EPA must review each registered pesticide at least every 15 years to determine whether it continues to meet the FIFRA registration standard. EPA has implemented an aggressive schedule to complete needed assessments for pesticides registered as of October 2007. In addition to EPA, a number of state agencies focus significant regulatory attention on pesticide practices. Pesticides are increasingly a subject of interest from public interest groups, public health activists, and communities. These extended interests add further layers to the complexity of challenges faced by registrants and other agricultural stakeholders.

Companies manufacturing the same active ingredient are urged to collaborate under FIFRA to share testing costs and conserve resources. Beyond tests, and as noted, pesticide stakeholders are increasingly challenged to address policy issues that warrant a coordinated advocacy strategy to ensure success and leverage resources. Having a group of like-minded entities organized and accustomed to working together before EPA initiates resources to reregister an active ingredient could prove to be a critical factor for success. This allows for a coordinated voice to address EPA, pool much needed use-specific information of application practices and exposure scenarios, gather information on what data are already available, and assess how those data should be applied in EPA's consideration of any additional data generation requirements.

The BCCM Ethylene Oxide Task Force, Metam Task Force, and Methyl Isothiocyanate (MITC) Task Force are currently engaged in advocacy, communications, and data development to support the continued U.S. registration of their products. With assistance from B&C professionals, BCCM groups are able efficiently to meet data production requirements, and obtain data compensation from appropriate others.

IRIS Reviews

Companies with chemicals subject to the Integrated Risk Information System (IRIS) assessment should be prepared to engage efficiently with EPA given that final IRIS hazard values are widely relied on by EPA program offices as well as state and local health agencies, other federal agencies, and international health organizations. Like other EPA programs, coordinated group advocacy is essential and the results of such action will carry more weight and garner more attention than individual entity input.

The IRIS process, which is managed by EPA's National Center for Environmental Assessment (NCEA), involves multiple phases. While stakeholders have several opportunities to engage with EPA, it is crucial that advocacy and cooperation among stakeholders begin early. The IRIS assessment itself represents the first part of the risk assessment process and can take many years to complete.

Within BCCM, several groups are actively engaged in or carefully monitoring the IRIS program, including the Ethylene Oxide Sterilization Association, Inc. (EOSA) and NAMC. The groups actively engage EPA through participation in public meetings and preparation of comments for consideration by EPA and its Science Advisory Board (SAB). When a substance is undergoing IRIS assessment, it is critical to conduct independent technical reviews of data and modeling. Existing consortia are able to complete these tasks swiftly and efficiently through the retention of expert consultants. Costs to individual entities are greatly reduced when this type of leveraged advocacy is performed by a consortium.

Policy Changes: Working Together for the Common Good

Recognizing problems within the current regulatory framework is easy; trying to resolve those problems can be difficult. Unless an entity wishes to spend a great deal of time and money, going it alone is not the best or only way to effectuate change and solve problems. By coordinating with other like-minded entities, flawed policies or misguided rules can be addressed leveraging the additional resources, coordinated advocacy, and strength offered by a consortium.

Several BCCM groups were formed specifically to address policy-related issues. The Alliance for Chemical Nomenclature (AChN) brings together companies and organizations engaged in the manufacture and/or use of fractionated chemical substances or other unknown, variable, complex, or biological substances, or otherwise have a vested interest in the commercial availability and regulatory TSCA classifications of such substances. AChN ensures its members' rights are adequately represented before EPA regarding the consequences of evolving, and often flawed, re-interpretations of TSCA nomenclature conventions that have significant commercial and enforcement consequences on AChN member companies. We need look no further than the current debacle involving EPA's medium and long chain chlorinated paraffins to appreciate the consequential legal, policy, and commercial implications of EPA's unlawful and misguided decision to interpret existing chemicals listed on the TSCA Inventory as "new" despite their robust commercial presence over the past 50 years in U.S. commerce.

The Industry Consortium for Environmental Measurement of Nanomaterials (ICEMN) was a consortium of industry, academic, and government stakeholders that recognized policy makers were not well-versed in available information on measuring nanomaterials in the environment. That group organized a highly successful workshop with the California Office of Environmental Health Hazard Assessment (OEHHA) and followed up with a series of articles about nanomaterial measurement in water, air, and soil that now serves as a practical guide for state and federal regulatory agencies.

Other BCCM groups working on important policy issues include the Biobased and Renewable Products Advocacy Group (BRAG®), NAMC, and the Titanium Dioxide Stewardship Council (TDSC).

BRAG members have long recognized that regulatory barriers exist for biobased chemistries and have coordinated efforts to address these regulatory hindrances and commercial inequities. BRAG has successfully advocated for reduced federal reporting requirements under the TSCA Chemical Data Reporting (CDR) that provides biodiesel manufacturers the same diminished reporting opportunities afforded petroleum-based diesel manufacturers -- saving the industry significant time, energy, and resources. In 2016, BRAG will continue to advocate policy changes related to naming differences for new biobased chemicals and their derivatives, even though those new chemicals are substantially similar in terms of functionality and chemical structure to older chemicals.

NAMC will continue its advocacy drum beat with EPA, Congress, state, and international organizations that metals have special attributes and behaviors that must be uniquely considered when assessing human health and ecological risks. The unique attributes are highlighted in the "Framework for Metals Risk Assessment," a science-based document that NAMC members worked closely with EPA in developing, and continue to emphasize as persistence, bioaccumulation, and toxicity (PBT) issues continue to be the subject of extraordinary government attention.

TDSC has and will continue to be actively engaged in proposed reporting and recordkeeping requirements impacting nanoscale materials. "Nano" issues extend far beyond the titanium dioxide (TiO2) industry and TDSC is one of many consortia that have engaged EPA on the issue. While these requirements impact many industries, TDSC members understood early on that the "strength in numbers" approach can extend beyond a particular industry segment. By working with other organizations, TDSC members see the benefit of working not only with competing companies, but with other industries, to advocate for a shared goal.

Product Stewardship: Collaboration Results in Improved Safety

While regulatory requirements are often a catalyst for companies to form an industry group, there are a growing number of "soft" non-regulatory factors that jump-start group formation. Industry leaders are often in the best position to execute needed changes within their sectors, which includes recognizing the need to promote important product stewardship activities related to research, worker safety, and/or communication needs across the value chain.

The BCCM Tetrahydrofuran Task Force (THF) has been deeply involved with voluntary research to understand better the mechanism of action related to certain hazard endpoints associated with THF. The Task Force appreciates that such proactive research can diminish areas of scientific uncertainty that would otherwise result in the application of uncertainty factors in regulatory contexts.

Recognizing the critical importance of an informed worker population, the Hydrogen Sulfide Coalition (H2S Coalition) is engaged in a unique program with the National Institute for Occupational Safety and Health (NIOSH) to develop educational and training materials covering the issues uniquely associated with H2S, including confined space, transportation, and handling issues spanning nearly 100 occupations across various industries. The H2S Coalition is able to address these concerns as it is a consortium consisting of multiple industry associations, each with their own member companies that collectively share an interest in H2S matters. This type of organization provides immense technical resources and expertise among the membership. Furthermore, it creates efficiency as multiple organizations are able to leverage time, resources, and costs required to address concerns.

One of BCCM's newer groups is the Aseptic and Antimicrobial Processing and Packaging Association. It is focused on the goal of enhancing industry practices to promote worker safety and protection. It is engaging food and beverage producers, processors, packaging suppliers, equipment manufacturers, and other stakeholders to enhance best practices for worker protection, spill clean-up, and other safety areas.

BCCM Services to Support All Consortia Goals

While the reasons for forming a consortium are varied, the objectives are the same -- to work together in a cost-effective manner in support of a common goal. BCCM can provide the necessary infrastructure, framework, and support to ensure that those goals are met quickly and efficiently.

BCCM creates and manages business consortia that have evolved in response to targeted advocacy, research, required product testing for entities in the industrial, agricultural, specialty chemical, or product/article area, or product stewardship interests. An industry group organized under BCCM allows for maximized impact because participants can leverage resources to address issues critically important to their needs and essential to their continued success.

All BCCM consortia work toward consensus decisions on issues related to membership dues, cost sharing for specific research programs, consideration of communication approaches, decisions on selection of testing laboratories, and advocacy strategies. BCCM recognizes that alignment among consortia members is essential for success and BCCM groups strive to achieve consensus decisions among members under the skilled, diplomatic, and experienced direction of BCCM staff. An important part of the decision-making process is the availability of carefully crafted and comprehensive bylaws that clearly identify the individual consortium's goals, objectives, work practices, and membership expectations. BCCM managers are sophisticated and experienced in the development and implementation of such bylaws as part of their day-to-day consortium management.

BCCM is unique in the services and talents it can offer its clients due to its affiliation with B&C, a Washington, D.C. law firm focusing on environmental and chemical control regulations, and The Acta Group (Acta®), a global regulatory and scientific consulting provider headquartered in Washington, D.C., with offices in Manchester, UK, and China.

BCCM is a core part of the B&C law firm's business platform to service clients efficiently. B&C has an international reputation for providing high-quality, cutting edge legal and regulatory counsel to Fortune 100 companies; medium size manufacturers; and trade associations and start-ups commercializing innovative, emerging technologies, including nanotechnology, biotechnology, and synthetic biology. B&C authored the report, "The DNA of the U.S. Regulatory System: Are We Getting It Right For Synthetic Biology?" B&C has been consistently ranked among the highest, most qualified firms by providing unfailing, spot-on legal advice, strategic counseling, and business acumen. Additional information is available at www.lawbc.com.

BCCM is also affiliated with Acta, an international consulting firm that offers a broad range of regulatory and scientific consulting services to entities worldwide. Acta focuses on chemical and other heavily regulated product approval issues and the supply chain notification, customer demand, communication, media attention, and regulatory issues associated with these regulatory requirements. Acta has been a consistent player in all matters under the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) legislation for over a decade, and is very much engaged in notifications and supply chain matters in China, Korea, Turkey, and elsewhere. More information on Acta is available at www.actagroup.com.

Given its affiliation with B&C and Acta, BCCM can provide its groups with immediate access to highly-trained, sophisticated attorneys, non-lawyer professionals, and scientists with significant expertise in competition law compliance, global chemical law and regulation, data management, data compensation, supply chain management, and regulatory and legal/policy guidance. The expansive talent pools at BCCM, B&C, and Acta allow for all-inclusive, comprehensive services in management, regulatory, and scientific efforts for a wide range of global chemical management systems and the business and legal issues these systems invite. Our team is deeply experienced in multiple scientific arenas, including food regulations, pesticides, risk assessment, computer modeling, chemical control efforts, nanotechnology, synthetic biology, and biofuels/biochemicals. Access to this pool of talent has proven to be an essential element in the success of BCCM's groups.

Administrative Services

BCCM's key management objective is to protect and immunize each consortium's interests from antitrust concerns, thereby allowing individual members to promote the consortium's goals. BCCM staff has more than 30 years of experience in managing and providing antitrust protection to various trade groups.

While antitrust protection is an important focus, BCCM provides comprehensive administrative, accounting, and communication support services that are necessary for a consortium's success, including coordination of all meetings/conference calls; maintenance of e-mail lists; collection and maintenance of confidential production or market share information for cost allocation purposes; providing for the amalgamation and protection of competitively sensitive information; membership recruitment; and website design and maintenance.

Regulatory Advocacy

BCCM's goal is to ensure each consortium's voice is heard on regulatory, scientific, legal, and related advocacy issues of interest to consortium members. BCCM often serves as the consortium's liaison with pertinent domestic and international regulatory agencies central to the consortium's issues. BCCM addresses regulatory advocacy needs for its clients, such as updating membership on significant regulatory, scientific, and legal issues relevant to the consortium's issues; engaging with regulatory groups to identify opportunities for coordination; networking with other groups on common areas of interest; preparing regulatory comments; and building and maintaining positive relationships with key state, federal, or international agencies/organizations, such as the EPA, the Occupational Safety and Health Administration (OSHA), Congress, the European Chemicals Agency (ECHA), the European Food Safety Authority (EFSA), and related entities.

Round-Robin Testing

BCCM has developed and executed round-robin analysis of consortia members' products in response to regulatory agency requests. These projects included obtaining and recording members' samples, blending those samples, coordinating with third parties for sample analysis, and developing final reports that provided relevant information while maintaining confidential business information. BCCM staff has also coordinated with B&C attorneys in the compilation and submission of market data to various agencies to demonstrate potential commercial impacts of proposed government actions.

In activities related to collection of sensitive business data, BCCM utilizes the B&C law firm's standard operating procedures (SOP) for protection of client records and information that specify locked files and disposal via shredding. BCCM staff engages B&C legal counsel in assessing, designing, and implementing identified data collection exercises to ensure they are compliant with all antitrust and competition sensitivities. In coordination with B&C attorneys, or a group's outside legal counsel and consortium representatives, BCCM staff works to identify the goal of the collection exercise, as well as the cohorts and timeframes, and assists in the preparation of surveys or other collection mechanisms. When information is submitted, BCCM staff follows established protocols and procedures on how to maintain the information, and engage in data analysis and aggregation suitable for public advocacy needs.

Research/Testing Programs

For groups wishing to engage in research or regulatory testing programs, BCCM can provide services associated with preparation of requests for proposals; negotiation of contracts with laboratories/testing facilities; provision of scientific counsel on test protocols and draft reports; regulatory and/or legal counsel on reporting obligations; and coordination and monitoring of testing activities, including updates to membership on key milestones and reporting obligations.

Often times, a consortium may undertake a research/testing program in response to regulatory requirements. Some consortia, however, elect to develop a voluntary research program. This may be done in support of product stewardship goals or to "get a jump" ahead of an anticipated, but not yet implemented, regulatory requirement. Such voluntary work can at times help guide a regulatory agency as it considers data that are important to its goal.

"Research work" is not completed simply because a final study report has been issued. BCCM also works with consortium members to manage the archival of important study materials to ensure all regulatory requirements are satisfied.

Communications

Many BCCM consortia engage in various public communication activities, ranging from developing and maintaining websites to creating a vibrant social media presence, to preparing press releases. As requested by the individual consortium, BCCM can provide membership updates on issues of concern; lists of chemical lists, summarizing all federal, state, and international lists on which chemicals of interest are included; alerts to consortium members of relevant industry/government developments; design and maintenance of public and private websites; development of professional brochures, advertising, promotional, and other informational materials (i.e., position statements, best practice guides); and development of product defense strategies, including draft press releases and related documents, formulated responses to media and other inquiries, and prepared question and answer documents.

In some instances, a consortium may wish to develop a communications program to respond to a significant advocacy need. In these cases, BCCM relies on past experiences with specialized communications firms to identify the most appropriate consultant to address the needs of the consortium. BCCM works with these firms to obtain focused and cost-effective proposals for the consortium members to review. Once a communications firm is selected, BCCM works to ensure all interests identified and public communication and outreach are managed effectively to leverage the group's investment in issue management and public outreach.

Financial Management Support

An often overlooked but critical service for industry groups is financial management. BCCM offers comprehensive and timely financial management support, which we believe is second to none. BCCM provides its consortia clients with a full line of accounting services, including preparing tax filings in all relevant jurisdictions; preparing financial statements; assisting with budgeting; invoicing member companies for annual fees, disbursements, and other expenses; remitting payments to contract laboratories, consultants, or other service providers as approved by the membership under contractually agreed upon conditions and schedules; maintaining consortium funds in a separate bank account; and collecting member payments and processing accounts payable.

All BCCM financial and tax preparation materials are prepared by a Certified Public Accountant (CPA).

Technology

BCCM groups enjoy the very latest in communication, meeting, and file management technology. Conferencing features are state of the art and include services ranging from basic audio teleconferences allowing for the participation of international callers to web-based meetings and video conferences. SharePoint sites are available and can be established to manage the development of complex documents requiring group input and review. When desired, websites are created quickly and managed efficiently using the latest software tools and resources. List serves are created and managed to optimize work flow and enhance communications with consortium members.

Mission Focused

BCCM management recognizes concerns with the "Hotel California" phenomena often associated with consortia groups. Once a group is formed, it often remains in existence, whether it is actively engaged in work, or not. That is not BCCM's philosophy. Our management approach is and always has been that a consortium should sunset when its goals are achieved. While some BCCM groups have long-term goals that may take years to achieve, others have very specific, very narrow program goals to achieve and will disband following that work. These groups have a beginning, a middle, and an end.

Examples of BCCM consortia that have sunset include the California Nano Industry Network (CalNIN) and the ICEMN. While these consortia sunset upon achieving their goals, the networks and relationships remain in place and could easily be reactivated should an issue arise in the future for which the industry wishes or needs to collaborate.

------------------

March 27, 2015
Interest in West Coast Sustainable Futures Training

Bergeson & Campbell, P.C. (B&C®) and its affiliate organizations are investigating the possibility of hosting a U.S. Environmental Protection Agency (EPA) Sustainable Futures workshop on the West Coast in late 2015. As you may know, Sustainable Futures training focuses on a variety of tools, methods, and models that can be used to assess the hazard and potential exposure of chemicals. The intensive, hands-on training provided at Sustainable Futures workshops allows attendees to utilize the EPA methods of hazard and risk screening for human health, ecotoxicity, and environmental fate, and learn directly from EPA professionals how best to apply these tools. Benefits for companies that engage in Sustainable Futures training include an option to manufacture sooner, and perhaps more important, the ability to reduce regulatory uncertainty for its new chemicals prior to EPA submission. Sustainable Futures participants are better positioned to anticipate and either avoid or control better hazardous conditions related to their chemicals of concern.

As part of our investigative process, we are asking our clients to weigh in on their interest for such a workshop on the West Coast -- recognizing the workshop involves three days of training by EPA staff at an anticipated cost of $1,500. Your response to this informal survey does not obligate you in any way, but would be extremely helpful to us as we contemplate whether to proceed with this EPA partnership.

Thank you in advance for your simple reply of either -- "Yes, I am interested" or "No, I am not interested." Replies should be sent to Kathleen M. Roberts at kroberts@lawbc.com.

January 21, 2014
EDSP Testing Consortia Forming Now to Meet EPA’s Deadline

B&C® Consortia Management, L.L.C. (BCCM) is assisting companies with forming testing consortia to fulfill regulatory requirements under the U.S. Environmental Protection Agency's (EPA) Endocrine Disruptor Screening Program (EDSP).

On June 14, 2013, EPA issued the final second list of chemicals and substances for Tier 1 screening under the EDSP. Our memorandum regarding this development is provided below. EPA has indicated that it will issue test orders for the Group 2 chemicals in batches, with the first batch to be issued soon.

The EDSP has an extremely short deadline, with only two years allowed for completion of the required tests, some of which take as long as 15 months. Companies that manufacture or import chemicals on the Group 2 list are urged to be proactive and work to establish a testing consortium NOW -- before a test order is issued. In addition to addressing the administrative organization issues prior to issuance of a test order, consortium members will have time to identify potential scientifically relevant information to submit to EPA in lieu of testing. It will also allow members to identify potential testing facilities, and even begin some testing -- if so desired -- before the order is issued. This permits companies to ease the financial burden of intense testing costs over the short two-year window provided by the EDSP.

BCCM can assist in identification and outreach to potential consortium members. Once the consortium is established, BCCM will work with the members to set up a budget, establish cost sharing agreements, outline testing schedules, and request bids. BCCM will manage all the administrative and financial issues associated with the consortium, including meetings/conference calls, bank accounts, tax accounting, and more. If desired by consortium members, BCCM can also offer toxicological expertise from experienced scientists with respect to placement and monitoring of the testing programs. This option may be of interest to companies that lack staff resources or expertise in toxicology testing. Complete information on BCCM staff and services is available at www.bc-cm.com.

In addition to the services offered by BCCM, because of its affiliation with Bergeson & Campbell, P.C. (B&C), BCCM has access to highly-trained, sophisticated attorneys and other professionals with significant expertise in regulatory law, data compensation, and EPA policy guidance. Test programs such as EDSP often present substantial risk information reporting questions, the answers to which experienced counsel may be needed. B&C is one of the few law firms in the country with a comprehensive domestic and international pesticide and industrial chemical practice group.

For more information or to discuss joining or forming an EDSP testing consortium, please contact Kathleen M. Roberts.

From Bergeson & Campbell, P.C.'s June 14, 2013, Clients and Friends Memorandum:

EPA Publishes Final EDSP Policies And Procedures And Final Second List Of Chemicals And Substances For Tier 1 Screening: On June 14, 2013, EPA published a Federal Register notice describing its final policies and procedures for requiring Tier 1 screening under the Endocrine Disruptor Screening Program (EDSP) of chemicals for which EPA may issue EDSP test orders pursuant to Section 1457 of the Safe Drinking Water Act (SDWA) and Section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA). 78 Fed. Reg. 35909. FFDCA Section 408(p) directed EPA to develop a chemical screening program using appropriate validated test systems and other scientifically relevant information (OSRI) to determine whether certain chemicals may have hormonal effects. These final policies and procedures supplement the EDSP policies and procedures that were published in the Federal Register on April 15, 2009. According to EPA, the 2009 policies and procedures were originally developed for screening pesticide chemicals and relied, in part, on a regulatory context that is specific to pesticide chemicals. EPA states that "the presumptions applicable in that context are not necessarily applicable to this larger universe of chemicals," which include chemicals used in pharmaceuticals and personal-care products, among others. In a separate Federal Register notice, also published June 14, 2013, EPA announced the final second list of 109 chemicals identified for Tier 1 screening under the EDSP. 78 Fed. Reg. 35922. The EDSP consists of a two-tiered approach to screen and test chemicals for potential endocrine disrupting effects. EPA states that the purpose of Tier 1 screening is to identify substances having the potential to interact with the endocrine system. Substances that have the potential to interact with estrogen, androgen or thyroid systems may proceed to Tier 2, which is designed to identify any adverse endocrine-related effects caused by the substance, and establish a quantitative relationship between the dose and that endocrine effect. EPA notes that the second list "should not be construed as a list of known or likely endocrine disruptors." More information regarding the EDSP is available online.

October 11, 2013
Kathleen M. Roberts Advocates for NMP Producers Group Before EPA Panel

Inside E.P.A. Weekly Report, October 11, 2013, featured comments made by Kathleen M. Roberts, Vice President of B&C affiliate Bergeson & Campbell Consortia Management, in “Industry Questions EPA Planning Of New TSCA Risk Assessment Program:”
“During the Sept. 26 meeting, the first of three peer review meetings, officials with the NMP Producers Group, an affiliate of the law firm Bergeson & Campbell, told the panelists reviewing DCM and NMP that similarities between industry criticism of those draft assessments and the ones for TCE shows EPA has failed to adequately plan the new program.

“Members of the NMP Producers Group said EPA’s draft assessment of NMP relies on inconsistent assumptions and unrealistic scenarios. EPA also used modeling to estimate certain exposures when agency contractors and industry have data representing actual exposures, the producers’ representatives said. ‘We see no benefit of a model that uses unrealistic assumptions and that gives results that are uncertain and unrealistic,’ Kathleen Roberts of the NMP Producers Group said.”

December 4, 2012
New Consortium Formed to Advance Biobased Products Policy and Regulatory Goals

Washington, D.C., December 4, 2012 -- B&C Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C. and The Acta Group, is pleased to announce the formation of the Biobased Products Advocacy Consortium (B2PAC), an organization that brings together leading innovators in the biobased chemical, biofuel, and renewable energy fields to pursue regulatory and policy advancement. Companies working to produce biobased chemical feedstocks and products have heretofore been under-represented in a number of regulatory and legislative areas; B2PAC members now have a collective advocacy voice at government agencies and on Capitol Hill.

B2PAC's focus issues include:

  • Regulatory Awareness and Relief -- The application of models and systems originally developed for petroleum-based feedstocks can delay or impede approval of biobased products and in some cases prevent their commercialization. B2PAC will address these obstacles and work to gain regulatory relief through policy awareness, education, and advocacy.
     
  • TSCA Requirements -- B2PAC helps members navigate the Toxic Substances Control Act (TSCA) "new chemicals" pre-market review process and assists in determining whether a chemical will be reviewed as "new" or existing, and to address these issues early as part of the development plan for a product or process.
     
  • Legislative Policies and Politics -- The consortium will advocate for provisions favorable to the biobased industry in the Farm Bill, the Biomass Crop Assistance Program, the Renewable Fuels Standard, and other appropriations. Consortium members will have a "ring-side" seat in this ongoing process and the political status of programs critical to them.

The article entitled "TSCA and the Regulation of Renewable Chemicals," written by Lynn L. Bergeson, Charles M. Auer, and Dr. R. David Peveler and published in Industrial Biotechnology, explains in more detail how TSCA may apply to biobased products.

For membership information, contact Kathleen M. Roberts, or visit the B2PAC website, www.b2pac.org.

July 12, 2012
B&C Consortia Management Website Redesign

Welcome to the newly redesigned B&C Consortia Management Website.

 


 
B&C CONSORTIA MANAGEMENT, L.L.C.
2200 Pennsylvania Ave, N.W. Suite 100W
Washington, D.C. 20037
(202) 833-6580 | bc-cm.com
Contact • Twitter
 
Privacy Policy 
©2017 B&C Consortia Management, L.L.C.
All Rights Reserved.